Cargando…

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease

Non‐alcoholic fatty liver disease (NAFLD) can progress to the more serious non‐alcoholic steatohepatitis (NASH), characterized by inflammatory injury and fibrosis. The pathogenic basis of NAFLD progressing to NASH is currently unknown, but growing evidence suggests MD2 (myeloid differentiation facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yali, Wu, Beibei, Zhang, Hailing, Ge, Xiangting, Ying, Shilong, Hu, Mengwei, Li, Weixin, Huang, Yi, Wang, Li, Chen, Chao, Shan, Xiaoou, Liang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783870/ https://www.ncbi.nlm.nih.gov/pubmed/29077272 http://dx.doi.org/10.1111/jcmm.13395

Ejemplares similares

Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury
por: Zhang, Yali, et al.
Publicado: (2016)

A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
por: Ge, Xiangting, et al.
Publicado: (2016)

A novel resveratrol analog PA19 attenuates obesity-induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration
por: Zhang, Wenxin, et al.
Publicado: (2019)

Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats
por: Shan, Xiaoou, et al.
Publicado: (2017)

Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2017)

Author Correction: Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
por: Xu, Zheng, et al.
Publicado: (2021)

Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway
por: Xu, Tingting, et al.
Publicado: (2019)

Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2
por: Wang, Yi, et al.
Publicado: (2017)

Author Correction: Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2
por: Wang, Yi, et al.
Publicado: (2018)

Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease
por: Huang, Chao, et al.
Publicado: (2022)

Blockade of myeloid differentiation protein 2 prevents obesity‐induced inflammation and nephropathy
por: Fang, Qilu, et al.
Publicado: (2017)

Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
por: Zhang, Yali, et al.
Publicado: (2014)

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease
por: Yan, Yan, et al.
Publicado: (2020)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Dietary Platycodon grandiflorus Attenuates Hepatic Insulin Resistance and Oxidative Stress in High-Fat-Diet Induced Non-Alcoholic Fatty Liver Disease
por: Ke, Weixin, et al.
Publicado: (2020)

Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS‐induced acute lung injury
por: Zhang, Yali, et al.
Publicado: (2016)

Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
por: Riezu-Boj, José I., et al.
Publicado: (2022)

Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease
por: Zhou, Yi, et al.
Publicado: (2020)

Selective targeting of MD2 attenuates intestinal inflammation and prevents neonatal necrotizing enterocolitis by suppressing TLR4 signaling
por: Huang, Dabin, et al.
Publicado: (2022)

EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation
por: Fang, Qilu, et al.
Publicado: (2016)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Effects of Fatty Alcohols with Different Chain Lengths on the Performance of Low pH Biomass-Based Foams for Radioactive Decontamination
por: Zhang, Hao, et al.
Publicado: (2022)

MD2 deficiency prevents high‐fat diet‐induced AMPK suppression and lipid accumulation through regulating TBK1 in non‐alcoholic fatty liver disease
por: Luo, Wu, et al.
Publicado: (2022)

Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway
por: Mei, Ying, et al.
Publicado: (2022)

Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
por: Deenin, Wanwisa, et al.
Publicado: (2021)

MD2 blockade prevents modified LDL-induced retinal injury in diabetes by suppressing NADPH oxidase-4 interaction with Toll-like receptor-4
por: Chen, Huaicheng, et al.
Publicado: (2021)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Association between ADIPOQ G276T and C11377G polymorphisms and the risk of non‐alcoholic fatty liver disease: An updated meta‐analysis
por: Liu, Mengwei, et al.
Publicado: (2019)

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
por: Zhou, Fei, et al.
Publicado: (2022)

Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
por: Tan, Si-hua, et al.
Publicado: (2023)

Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model
por: Huang, Huping, et al.
Publicado: (2019)

EGFR Inhibition Blocks Palmitic Acid-induced inflammation in cardiomyocytes and Prevents Hyperlipidemia-induced Cardiac Injury in Mice
por: Li, Weixin, et al.
Publicado: (2016)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
por: Teng, Yu-Xian, et al.
Publicado: (2022)

Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice
por: Karimian, Golnar, et al.
Publicado: (2015)

Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro
por: Liu, Xiao-Yan, et al.
Publicado: (2023)

Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes
por: Zhang, Yali, et al.
Publicado: (2020)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
por: Yang, Ying, et al.
Publicado: (2021)

TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis
por: Li, Jie, et al.
Publicado: (2017)

Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
por: Pei, Erli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t5t8sdopk5glqokj0nviccg9eb